1. Home
  2. CRNX vs INDB Comparison

CRNX vs INDB Comparison

Compare CRNX & INDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$41.08

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo Independent Bank Corp.

INDB

Independent Bank Corp.

HOLD

Current Price

$78.90

Market Cap

3.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNX
INDB
Founded
2008
1907
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.8B
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
CRNX
INDB
Price
$41.08
$78.90
Analyst Decision
Strong Buy
Hold
Analyst Count
8
4
Target Price
$76.75
$87.00
AVG Volume (30 Days)
968.2K
316.5K
Earning Date
05-07-2026
04-16-2026
Dividend Yield
N/A
3.32%
EPS Growth
N/A
N/A
EPS
N/A
4.44
Revenue
$1,039,000.00
N/A
Revenue This Year
$720.10
$33.83
Revenue Next Year
$184.67
$5.85
P/E Ratio
N/A
$17.57
Revenue Growth
N/A
N/A
52 Week Low
$25.83
$59.61
52 Week High
$57.99
$87.00

Technical Indicators

Market Signals
Indicator
CRNX
INDB
Relative Strength Index (RSI) 60.96 56.25
Support Level $39.88 $77.79
Resistance Level $41.33 $82.68
Average True Range (ATR) 1.52 1.72
MACD 0.27 -0.03
Stochastic Oscillator 76.34 71.92

Price Performance

Historical Comparison
CRNX
INDB

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

About INDB Independent Bank Corp.

Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.

Share on Social Networks: